Free Trial

Amrize (NYSE:AMRZ) Upgraded by Wells Fargo & Company to "Strong-Buy" Rating

Amrize logo with Basic Materials background

Key Points

  • Amrize (NYSE:AMRZ) has been upgraded to a "strong-buy" rating by Wells Fargo & Company, signaling increased confidence in the stock's performance.
  • Despite a mixed bag of ratings from various analysts, Amrize has a consensus rating of "Moderate Buy" and a target price of $58.25.
  • Recent insider activity indicates strong buying interest, with significant purchases totaling over $53 million in shares by company insiders in the last three months.
  • Five stocks we like better than Amrize.

Amrize (NYSE:AMRZ - Get Free Report) was upgraded by equities research analysts at Wells Fargo & Company to a "strong-buy" rating in a report released on Wednesday,Zacks.com reports.

AMRZ has been the topic of several other reports. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Amrize in a research report on Wednesday. Royal Bank Of Canada decreased their target price on Amrize from $61.00 to $54.00 and set an "outperform" rating for the company in a research note on Friday, August 8th. Oppenheimer initiated coverage on Amrize in a research note on Tuesday, September 9th. They set an "outperform" rating and a $62.00 target price for the company. Zacks Research downgraded Amrize from a "hold" rating to a "strong sell" rating in a research note on Wednesday, August 27th. Finally, Barclays began coverage on Amrize in a research note on Tuesday. They set an "equal weight" rating for the company. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Amrize has a consensus rating of "Moderate Buy" and a consensus target price of $58.25.

View Our Latest Research Report on Amrize

Amrize Price Performance

NYSE:AMRZ opened at $48.09 on Wednesday. Amrize has a 1-year low of $44.12 and a 1-year high of $56.29. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The company's fifty day simple moving average is $50.78.

Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.03 by ($0.25).

Insider Buying and Selling

In related news, insider Jaime Hill purchased 4,000 shares of Amrize stock in a transaction dated Friday, August 15th. The shares were acquired at an average cost of $51.99 per share, for a total transaction of $207,960.00. Following the transaction, the insider directly owned 13,601 shares of the company's stock, valued at approximately $707,115.99. This trade represents a 41.66% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Mario Gross bought 3,000 shares of Amrize stock in a transaction on Wednesday, August 13th. The shares were acquired at an average price of $49.63 per share, for a total transaction of $148,890.00. Following the completion of the acquisition, the insider owned 23,232 shares of the company's stock, valued at approximately $1,153,004.16. This represents a 14.83% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders acquired 1,124,000 shares of company stock worth $53,225,260.

Institutional Trading of Amrize

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. acquired a new stake in shares of Amrize in the second quarter valued at about $1,065,029,000. Norges Bank acquired a new stake in shares of Amrize in the second quarter valued at about $670,915,000. Dodge & Cox acquired a new stake in shares of Amrize in the second quarter valued at about $622,085,000. JPMorgan Chase & Co. acquired a new stake in shares of Amrize in the second quarter valued at about $220,404,000. Finally, Legal & General Group Plc acquired a new stake in shares of Amrize in the second quarter valued at about $161,761,000.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Analyst Recommendations for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.